| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43062ef3cac5eaf235c92c8c945609b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fbdfebf6da1ebacf98fe75056acea1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f6e4b9d70b1d5bc7e837dc9b98fcac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1636e84fffafc3b73b79b92758ec724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a61339c9dcb5a5496e7af0f05bcee88 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 |
| filingDate |
2008-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26598401c8403b030fac665bdc79d521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b432ea9bd3c11907651aea89a5ccbb04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1663ef79ace282cc22ea01a810d8702d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7c72c0e8f428a93213c78fb84c1dd39 |
| publicationDate |
2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009058835-A1 |
| titleOfInvention |
Method of determining vaccine compliance |
| abstract |
A protein (xylanase) has been identified that produces a strong immune response in pigs when added to a vaccine. The protein is added to vaccines at a particular concentration. The protein is delivered to the animal as part of the vaccine and elicits an immune reaction (antibodies are generated by the animal against the compliance marker protein). The antibodies are then detected in sera samples by a diagnostic test, enzyme- linked immunosorbent assay (ELISA). hi the ELISA compliance marker assay, the marker protein (antigen) in coated onto polystyrene plates and is used to detect antibodies against the marker in sera samples. This combination of marker protein added to vaccines and the ELISA to detect antibodies raised against the marker protein can be used to determine whether a particular animal(s) has been vaccinated. The selected protein is commercially-available, identified as Generally Recognized as Safe by the FDA, and does not cause adverse reactions in animals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016160761-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016141338-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019121414-A1 |
| priorityDate |
2007-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |